Barleria lupulina
Barleria lupulina · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Barleria lupulina is a medicinal plant whose leaves have garnered significant scientific interest due to their diverse therapeutic potential. Research indicates that various preparations, including crude, hot aqueous, and chloroform extracts, possess potent antimicrobial, antioxidant, and cytotoxic activities. These biological effects are largely attributed to key chemical constituents such as 4-Ethylcatechol, 4-Methylcatechol, 4-Vinylcatechol, and Acetylbarlerin. Consequently, the plant shows promise in addressing complex medical conditions ranging from inflammation and cancers to diabetic vascular complications. Furthermore, its unique pharmacological profile suggests potential applications in managing age-related macular degeneration and osteoporotic conditions.
- Synonyms
- Barleria Monostachya · Dicliptera Spinosa
- Common names
- Not available
- Family
- Acanthaceae
- Distribution
- Africa
- Plant Parts
- Leaf
Classification
Common Names
Barleria lupulina is a versatile plant known by a wide variety of regional and descriptive names. In many areas, it is affectionately referred to as Hophead Philippine violet or simply hop-headed barleria due to its distinct floral structure. Depending on the local dialect, you might also hear it called Landik or Barré bolé. Its identity even extends into different linguistic traditions, such as the name Барлерия волчья used in Russian contexts. Understanding these diverse common names helps enthusiasts identify this unique species across different cultures and geographies.
Sources: Catalogue of Life (COL)
Synonyms
Barleria lupulina is a botanical subject often identified by several different names within scientific literature. It is widely recognized as being synonymous with Barleria monostachya in various taxonomic records. Additionally, this plant is frequently referred to by the synonym Dicliptera spinosa. Understanding these overlapping nomenclatures is essential for accurate plant identification and study. Recognizing these relationships ensures that researchers can maintain consistency across different botanical databases.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Barleria lupulina is a fascinating botanical specimen that belongs to the vast kingdom Plantae. Within this expansive kingdom, the plant is classified under the class Equisetopsida. It further belongs to the order Lamiales, a group that defines many of its structural characteristics. As a member of the family Acanthaceae, it shares unique traits with many other diverse species in that lineage. Ultimately, this specific plant is identified by its unique place within the genus Barleria.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Acanthaceae |
| Genus | Barleria |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Barleria lupulina exhibits a broad and diverse geographical distribution across the African continent. In West Tropical Africa, this species can be found thriving in regions such as Benin and Burkina Faso. Its presence extends significantly eastward into the Western Indian Ocean, establishing a footprint in various island territories. Specifically, the plant is known to inhabit the lush landscapes of Madagascar and the Comoros. Additionally, its range reaches as far as Mauritius, showcasing its ability to adapt to different island environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Barleria lupulina is a self-supporting shrub that establishes a sturdy presence in its natural habitat. This resilient plant typically reaches a maximum height of 1.5 meters as it matures. Its compact growth form makes it a distinctive feature of the local landscape.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Barleria lupulina is a versatile medicinal plant that exhibits a wide range of significant biological activities. Research indicates that it possesses strong antimicrobial effects, particularly in inhibiting bacteria that cause acne. Furthermore, the plant shows promising antiosteoporotic potential through its ability to enhance alkaline phosphatase activity in osteoblast cells. Studies also highlight its antioxidant properties and its ability to reduce reactive oxygen species within cellular environments. Finally, its concentration-dependent cytotoxic effects against various cancer cell lines suggest it may serve as a valuable resource for future anticancer therapies.
Compounds
Barleria lupulina is a medicinal plant recognized for its significant antioxidant, anti-inflammatory, and cytotoxic properties. Phytochemical profiling of its extracts has revealed the presence of several key bioactive compounds, including acetylbarlerin and decaffeoylacteoside. Research specifically highlights the importance of alkyl catechols found within the plant, such as 4-ethylcatechol, 4-methylcatechol, and 4-vinylcatechol. These specific compounds are known to potently activate the Nrf2 cell defense pathway, which helps reduce inflammation and improve endothelial cell health. Ultimately, the diverse chemical makeup of Barleria lupulina supports its therapeutic potential in treating inflammatory conditions and various types of cancer.
Conditions
Barleria lupulina demonstrates significant medicinal potential through its ability to treat the parasite Entamoeba histolytica strain HM1:IMSS. The plant also exhibits strong inhibitory effects against the acne-causing bacteria Propionibacterium acnes. Furthermore, its hot aqueous extracts activate the Nrf2 cell defense pathway, which is associated with the prevention of cancers. This activation also suggests a therapeutic role in treating age-related macular degeneration. Finally, the plant's properties may help reduce the severity of chronic obstructive pulmonary disorder.
Preparations
Barleria lupulina is prepared as crude extracts to demonstrate strong inhibitory effects against acne-inducing bacteria such as Propionibacterium acnes. This medicinal plant is also prepared as hot aqueous extracts, which are utilized for treating inflammatory conditions and diabetic vascular complications by activating the Nrf2 cell defense pathway. Furthermore, Barleria lupulina is prepared as chloroform extracts that exhibit active anti-amoebic properties against Entamoeba histolytica. Research also shows the plant is prepared as an extract to identify potent iridoid glucosides that enhance alkaline phosphatase activity. Finally, Barleria lupulina is prepared as a leaf extract to assess its significant cytotoxic and proapoptotic potential against colon and lung cancer cell lines.
Parts used
Barleria lupulina is a medicinal plant native to India, South China, and Southeast Asia that possesses notable antioxidant and cytotoxic properties. Recent scientific investigations have focused specifically on the plant's leaf, utilizing ethanolic extracts to explore its potential as an anticancer agent. Through phytochemical profiling, researchers identified several bioactive compounds within the leaf, such as gallic acid and decaffeoylacteoside. These components demonstrate significant antiproliferative effects by inducing apoptosis in both colon and lung cancer cell lines. Ultimately, the study confirms that the leaf extract serves as a promising resource for developing new cancer therapies.